In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis

Chemotherapy-induced oral mucositis is a painful and debilitating side effect that affects many cancer patients undergoing treatment. This study by Shao, Chen, Lin, and colleagues developed an innovative mucoadhesive hydrogel system to deliver the anti-inflammatory tripeptide KPV directly to oral mucosal tissues.

The researchers designed an in situ mucoadhesive hydrogel capable of capturing and sustainably releasing KPV at the site of oral mucosal injury. They tested this delivery system in a model of chemotherapy-induced oral mucositis, evaluating anti-inflammatory, antibacterial, and tissue-repair outcomes.

The KPV-loaded hydrogel demonstrated potent multi-faceted therapeutic effects, simultaneously reducing inflammation, fighting bacterial infection, and promoting tissue repair in chemotherapy-damaged oral mucosa. This triple-action approach effectively treated the complex pathology of oral mucositis.

For cancer patients enduring the painful effects of chemotherapy on oral tissues, this study offers a promising treatment approach. The combination of KPV's natural anti-inflammatory properties with an advanced delivery system represents a sophisticated solution that addresses oral mucositis from multiple angles, potentially improving quality of life during cancer treatment.